According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain. “
Grifols SA (NASDAQ:GRFS) opened at 15.72 on Wednesday. The stock has a 50 day moving average price of $16.09 and a 200-day moving average price of $16.04. The firm has a market capitalization of $21.48 billion, a PE ratio of 35.65 and a beta of 0.92. Grifols SA has a 12-month low of $14.07 and a 12-month high of $18.04.
Institutional investors have recently modified their holdings of the company. PNC Financial Services Group Inc. raised its position in shares of Grifols SA by 22.0% in the second quarter. PNC Financial Services Group Inc. now owns 6,870 shares of the company’s stock worth $114,000 after buying an additional 1,239 shares during the period. Societe Generale acquired a new position in shares of Grifols SA during the second quarter worth about $139,000. SG Americas Securities LLC acquired a new position in shares of Grifols SA during the second quarter worth about $139,000. Quantbot Technologies LP raised its position in shares of Grifols SA by 3,328.7% in the second quarter. Quantbot Technologies LP now owns 8,366 shares of the company’s stock worth $139,000 after buying an additional 8,122 shares during the period. Finally, Walleye Trading LLC raised its position in shares of Grifols SA by 31.0% in the second quarter. Walleye Trading LLC now owns 9,300 shares of the company’s stock worth $155,000 after buying an additional 2,200 shares during the period. 20.18% of the stock is owned by institutional investors and hedge funds.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Grifols SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grifols SA and related companies with MarketBeat.com's FREE daily email newsletter.